Valeant Recalls Subpotent AcneFree Oil-Free Acne Cleanser
Valeant Pharmaceuticals is recalling AcneFree Oil-Free Acne Cleanser because the benzoyl peroxide ingredient is subpotent and the label contains errors regarding inactive ingredients.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The issues involve subpotency and labeling errors, fitting the criteria for moderate severity.
Plain-English summary
Valeant Pharmaceuticals is recalling 145,650 bottles of AcneFree Oil-Free Acne Cleanser (benzoyl peroxide 2.5% w/v), 8 fl. oz. (237 mL) bottles. The product is distributed by University Medical Pharmaceuticals Corp. in Irvine, CA, and was sold nationwide. The recall covers all lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 12020 8.
The recall was initiated because the product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, the product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.
Consumers should check their products for the specific UPC and expiration date range listed above. If the product matches the description, consumers should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- AcneFree Oil-Free Acne Cleanser (benzoyl peroxide 2.5% w/v), 8 fl. oz. (237 mL) bottle, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA 92618, AFCS-0101-00, UPC 7 88521 12020 8.
- Manufacturer
- Valeant Pharmaceuticals
- Category
- Drug — Topical OTC
- Affected units
- 145,650
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Valeant Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Valeant Pharmaceuticals
See all →- LowValeant Recalls Subpotent AcneFree 3-in-1 Acne Night Repair Foam
FDA (Drugs) · 2012-11-14
- ModerateValeant Recalls Subpotent AcneFree 24 Hour Severe Acne Clearing System
FDA (Drugs) · 2012-11-14
- ModerateValeant Recalls Subpotent AcneFree Benzoyl Peroxide Tubes Nationwide
FDA (Drugs) · 2012-11-14
- ModerateValeant Recalls Subpotent AcneFree Acne Pore Cleanser
FDA (Drugs) · 2012-11-14
- LowFDA Recalls Subpotent AcneFree Benzoyl Peroxide Cleanser
FDA (Drugs) · 2012-11-14
Same hazard · subpotent drug
See all →- LowImprimisRx Recalls Subpotent Povidone Iodine and Proparacaine Ophthalmic Solution
FDA (Drugs) · 2026-09-16
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
Similar recalls
- ModerateAllergan Recalls Subpotent Skin Medica Acne Treatment Lotion
FDA (Drugs) · 2020-08-05
- LowValeant Recalls CLENZIderm M.D. Acne Treatment Kits Due to Discoloration
FDA (Drugs) · 2017-04-26
- HighWalgreens Acne Control Cleanser recalled for benzene contamination
FDA (Drugs) · 2025-03-19
- SevereSkin MD Body Acne Cleanser recalled due to elevated benzene levels
FDA (Drugs) · 2025-10-01
- LowAllergan Recalls Skin Medica Acne System Kits for Subpotency
FDA (Drugs) · 2020-08-05
- ModerateLa Roche-Posay Effaclar Duo Acne Treatment Recalled for Benzene Contamination
FDA (Drugs) · 2025-05-21